SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON CHELATORS

Information

  • Research Project
  • 3507325
  • ApplicationId
    3507325
  • Core Project Number
    R44DK037207
  • Full Project Number
    2R44DK037207-02
  • Serial Number
    37207
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1987 - 37 years ago
  • Project End Date
    8/31/1989 - 35 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/1987 - 37 years ago
  • Budget End Date
    8/31/1988 - 36 years ago
  • Fiscal Year
    1987
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/30/1987 - 37 years ago

SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON CHELATORS

In chemical and biological systems, iron is both ubiquitous and highly reactive. In a variety of circumstances, there is great need for new approaches to the removal of iron or the control of its reactivity. We have produced a series of high molecular weight iron chelators based on derivatization of a number of substrates with deferoxamine B. This chelator has an extremely high affinity for iron and is very selective (i.e., has relatively low affinity for other polyvalent cations aside from aluminum). We have produced adducts between deferoxamine B and both soluble polymers and solid matrices. The present proposal relates to maximization of derivatization procedures, definition of appropriate conditions of modification, and, finally, determination of the physical characteristics of the derivatized materials. The high molecular weight iron chelators produced as a result of this work have a number of potential (i.e., Phase II) applications. These include: (1) the selective and quantitative removal of iron from solutions, (2) a simple and rapid procedure for serum iron determination, (3) more effective iron chelation therapy, and (4) the control of bacterial infections which are promoted by free iron.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R44
  • Administering IC
    DK
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    BIO
  • Study Section Name
    Biochemistry Study Section
  • Organization Name
    BIOMEDICAL FRONTIERS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    MINNEAPOLIS
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    55414
  • Organization District
    UNITED STATES